https://www.indianpharmapost.com/gland-pharma-posts-q2-fy24-consolidated-pat-at-rs-19408-cr-148692023-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/sun-pharma-advanced-research-posts-q2-fy24-loss-at-rs-8642-cr-148702023-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/max-healthcare-institute-reports-q2-fy24-consolidated-pat-at-rs-27668-cr-148712023-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/divis-laboratories-posts-q2-fy24-consolidated-pat-at-rs-348-cr-148722023-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-wellness-consolidated-q2-fy24-pat-drops-to-rs-59-cr-148732023-11-07T00:00:00+05:30always0.9